Integrated Biopharma Inc (INBP): Operating Income
-$2.71M
Year ended 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$2.71M | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | $2.02M | +704.8% | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | $251.0K | +109.2% | 2025-09-23, From 2023-07-01 |
| 2023-06-30 | $120.0K | -95.6% | 2024-09-20, From 2022-07-01 |
| 2022-06-30 | $2.75M | -52.5% | 2023-09-15, From 2021-07-01 |
| 2021-06-30 | $5.78M | +77.5% | 2022-09-13, From 2020-07-01 |
| 2020-06-30 | $3.26M | +20.5% | 2021-09-02, From 2019-07-01 |
| 2019-06-30 | $2.70M | +59.6% | 2020-09-23, From 2018-07-01 |
| 2018-06-30 | $1.69M | -46.8% | 2019-08-29, From 2017-07-01 |
| 2017-06-30 | $3.19M | +50.8% | 2018-09-12, From 2016-07-01 |
| 2016-06-30 | $2.11M | +126.6% | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | $933.0K | -31.0% | 2016-09-02, From 2014-07-01 |
| 2014-06-30 | $1.35M | +21.1% | 2015-09-04, From 2013-07-01 |
| 2013-06-30 | $1.12M | n/m | 2014-09-08, From 2012-07-01 |
| 2012-06-30 | -$506.0K | n/m | 2013-09-30, From 2011-07-01 |
| 2011-06-30 | -$362.0K | n/a | 2012-10-15, From 2010-07-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Integrated Biopharma Inc (INBP) | 2026-06-30 | -$2.71M | n/m |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | -$41.98M | n/m |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | -$2.79M | n/m |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | -$71.05M | n/m |
| Wave Life Sciences, Inc. (WVE) | 2025-12-31 | -$215.38M | n/m |
| Septerna, Inc. (SEPN) | 2025-12-31 | -$68.30M | n/m |
| Protagonist Therapeutics, Inc (PTGX) | 2025-12-31 | -$158.13M | n/m |
| Biofrontera Inc. (BFRI) | 2025-12-31 | -$11.35M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$170.73M | n/m |
Compare INBP, XLO, CPIX, AQST side by side · Screen every company in Pharmaceutical Preparations ↗